Last Posted: Feb 02, 2019
- https://www.nytimes.com/interactive/2019/02/01/opinion/23andme-cancer-dna-test-brca.html
Oncology Nurse Advisor, February 1, 2019 - Why You Should Be Careful About 23andMe’s Health Test
New York Times editorial, February 1, 2019 - BRCA mutation screening and patterns among high-risk Lebanese subjects.
Farra Chantal et al. Hereditary cancer in clinical practice 2019 174 - Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need.
Hong Soo Jung et al. Journal of genetic counseling 2019 Jan - Pilot study of rapid MR pancreas screening for patients with BRCA mutation.
Corrias Giuseppe et al. European radiology 2019 Jan - Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
Morgan Robert D et al. Journal of medical genetics 2019 Jan - Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations.
Powell C Bethan et al. Gynecologic oncology 2018 151(3) 489-493 - Development and Testing of a Decision Aid for Unaffected Women with a BRCA1 or BRCA2 Mutation.
Jabaley Terri et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2019 Jan - Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes.
Bucheit Leslie et al. Hereditary cancer in clinical practice 2019 172 - Oophorectomy and breast cancer in BRCA mutation carriers--letter.
Berrino Franco et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Aug 21(8) 1389
No hay comentarios:
Publicar un comentario